Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Disintegration Tester Testing Methods

Disintegration testing is a critical quality control process used in the pharmaceutical industry to evaluate the physical properties of solid dosage forms. This article provides a comprehensive technical overview of disintegration tester methodologies, covering apparatus specifications, operating procedures, and compliance with international pharmacopoeia standards to ensure product efficacy and safety.

Technical Overview

The disintegration test is a crucial in-vitro quality control test performed on solid oral dosage forms such as tablets, capsules, and granules. It measures the time required for a dosage form to break down into granules or smaller particles under standardized conditions. This test does not imply complete dissolution but ensures that the active pharmaceutical ingredient (API) is released for subsequent absorption in the body. The method relies on a specialized apparatus designed to simulate the mechanical agitation and fluid environment of the gastrointestinal tract.

The apparatus typically consists of a basket-rack assembly that moves vertically at a constant frequency within a controlled temperature medium. Compliance with standards such as the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and other national standards like GB or JIS is essential for validating the test results.

Testing Samples

The disintegration test is applicable to a wide variety of solid dosage forms. The specific testing parameters may vary slightly depending on the physical characteristics and intended release profile of the sample.

Uncoated Tablets

Standard uncoated tablets are the most common subjects for this test. They are expected to disintegrate rapidly to facilitate quick release of the drug. The test typically utilizes water or simulated gastric fluid as the medium.

Coated Tablets

Film-coated or sugar-coated tablets require the disintegration of the coating layer followed by the core. The test method may require a longer duration or specific discs to ensure the coating does not hinder the breakdown of the core material.

Capsules

Hard and soft gelatin capsules are tested to ensure the shell dissolves or ruptures, releasing the contents. Special attention is paid to the medium temperature, as gelatin can cross-link and affect the test validity.

Testing Items

The primary objective of the test is to verify that the product meets the disintegration time limits specified in the relevant pharmacopoeia monograph. Key testing parameters include:

  • Disintegration Time: The period between the start of the test and the moment no residue remains on the screen of the apparatus.
  • Medium Temperature: Maintained typically at 37°C ± 1°C to simulate body temperature.
  • Volume of Medium: Usually 800ml to 1000ml, ensuring the basket is fully submerged during the cycle.
  • Disc Weight: The use of a disc is often mandatory for coated tablets or capsules to provide mechanical pressure and prevent floating.

Testing Methods

The standard operating procedure for disintegration testing involves precise setup and monitoring to ensure reproducibility. The following steps outline the general methodology.

Apparatus Preparation

Ensure the disintegration tester is level and clean. Fill the beakers with the specified medium (usually water, simulated gastric fluid, or simulated intestinal fluid). Heat the medium until it reaches a stable temperature of 37°C ± 1°C. The medium should be stirred gently to maintain uniform temperature without creating air bubbles.

Sample Loading

Place one dosage unit in each of the six tubes of the basket-rack assembly. Unless otherwise specified in the individual monograph, add a disc to each tube. The disc acts as a weight to keep the sample submerged and provides mechanical stress.

Operation and Observation

Lower the basket-rack assembly into the medium and start the timer. The apparatus will perform vertical reciprocating movements at a frequency of 29–32 cycles per minute. Operators must observe the samples periodically without lifting the basket out of the medium for extended periods.

Endpoint Determination

The test is considered complete when all dosage units have disintegrated completely. Complete disintegration is defined as the state where no residue remains on the screen of the apparatus, except for fragments of insoluble coating or capsule shell. If one or two units fail to disintegrate, a repeat test may be required with an additional 12 units, where at least 16 of the total 18 units must pass.

Applications

Disintegration testing serves multiple critical functions in the pharmaceutical and nutraceutical industries:

  • Quality Control (QC): Used as a routine batch release test to ensure consistency in manufacturing processes.
  • Research and Development: Helps formulators evaluate the impact of excipients, binder concentrations, and compression forces on tablet hardness and breakdown.
  • Stability Studies: Monitors changes in disintegration time over the shelf life of a product under various storage conditions.
  • Generic Drug Development: Essential for demonstrating bioequivalence by matching the disintegration profile of reference listed drugs.

FAQ

What is the difference between disintegration and dissolution?

Disintegration measures the physical breakdown of a dosage form into smaller particles, while dissolution measures the rate at which the active pharmaceutical ingredient dissolves into a solvent. Disintegration is a prerequisite for dissolution in many solid dosage forms, but a product that disintegrates rapidly does not necessarily dissolve rapidly.

Why is the disc used in disintegration testing?

The disc serves two primary purposes: it prevents floating dosage forms (like capsules or light tablets) from rising out of the medium, and it applies a slight mechanical pressure to aid in the breakdown of the sample, simulating the peristaltic movement of the GI tract.

How is the temperature controlled?

Temperature is controlled using a built-in heater and thermostat within the water bath of the disintegration tester. The medium temperature must be verified using a calibrated thermometer before the test begins to ensure it remains within the strict tolerance of 37°C ± 1°C.

Why Choose ZKGX?

  • State-of-the-art analytical equipment
  • Highly qualified scientific team
  • Fast turnaround time
  • Competitive pricing